Clinical Trials Directory

Trials / Completed

CompletedNCT04579289

Managerial and Environmental Risk for COVID 19 in French Long Term Care Institutions

Managerial and Environmental Risk for COVID 19 in French Long Term Care Institutions_COVID-19

Status
Completed
Phase
Study type
Observational
Enrollment
230 (actual)
Sponsor
Rennes University Hospital · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

REMPAR EHPAD study addresses environmental and managerial factors associated with an outbreak of COVID 19 in French Long Term Care Institutions in the spring of 2020. The survey used a mixed methodology, combining qualitative and quantitative approaches, with a questionnaire send to all identified institutions (n=501) and qualitative interviews with facility directors (n=21).

Detailed description

1. Declarative retrospective survey : A questionnaire was e-mailed to all identified institutions, with 3 reminders in one month. It included 39 questions concerning : * morbidity and mortality linked with COVID-19 * structural features of the facility (location, architecture, residents characteristics) * human resources * crisis management (visits and circulation restrictions, personal protective equipment) A statistical analysis by logistic regression will be made, to identify explanatory variables for the occurrence of at least one COVID 19 infection among the residents. 2. Qualitative survey : The investigators conducted semi-directed face-to-face interviews with facility directors. The investigators realized a purposive sample to assure maximal variability of the facilities (location, size, status, severity of the outbreak). The interview guide focused on structural, organizational, and human factors at stake in outbreak management, to identify incentives and obstacles associated with an easier crisis management.

Conditions

Interventions

TypeNameDescription
OTHERquestionnaireA questionnaire was e-mailed to all identified institutions, with 3 reminders in one month. It included 39 questions concerning : * morbidity and mortality linked with COVID-19 * structural features of the facility (location, architecture, residents characteristics) * human resources * crisis management (visits and circulation restrictions, personal protective equipment)

Timeline

Start date
2020-06-15
Primary completion
2020-09-01
Completion
2020-09-01
First posted
2020-10-08
Last updated
2020-10-14

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04579289. Inclusion in this directory is not an endorsement.